Officials with the Food and Drug Administration (FDA) recently joined scientists at a public meeting on next steps for conducting research to develop psychedelic medicines. During the two-day event hosted by the Reagan-Udall Foundation earlier this month, multiple FDA representatives discussed the agency’s work to promote clinical trials into the therapeutic potential of substances such … Continue reading FDA Officials Join Experts To Discuss Psychedelics Research Challenges And Promises